The News

NHS pilots genetic testing to predict risk of heart disease


17 Jan 2022

An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.

Visit website

Genomics plc announces extension of drug discovery collaboration with Vertex


3 Nov 2021

Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery

Read article

NHS launches new polygenic scores trial for heart disease


29 Apr 2021

The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.

Visit website

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities


6 Apr 2021

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

Read article

NHS pilots genetic testing to predict risk of heart disease


17 Jan 2022

An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.

Genomics plc announces extension of drug discovery collaboration with Vertex


3 Nov 2021

Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery

NHS launches new polygenic scores trial for heart disease


29 Apr 2021

The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities


6 Apr 2021

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

Sir Peter Donnelly gives Plenary Keynote at ELRIG Research & Innovation 2021


23 Mar 2021

Empowering Drug Discovery through Genomics

NHS pilots genetic testing to predict risk of heart disease


17 Jan 2022

An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.

Genomics plc announces extension of drug discovery collaboration with Vertex


3 Nov 2021

Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery

NHS launches new polygenic scores trial for heart disease


29 Apr 2021

The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities


6 Apr 2021

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

Sir Peter Donnelly gives Plenary Keynote at ELRIG Research & Innovation 2021


23 Mar 2021

Empowering Drug Discovery through Genomics

NHS pilots genetic testing to predict risk of heart disease


17 Jan 2022

An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.

Visit website

Genomics plc announces extension of drug discovery collaboration with Vertex


3 Nov 2021

Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery

Read article

NHS launches new polygenic scores trial for heart disease


29 Apr 2021

The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.

Visit website

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities


6 Apr 2021

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

Read article